Jr. Michael Conick Hanley

Insider Reports History

Entity
Individual
Location
C/O Aeglea Therapeutics, Inc., 901 S. Mopac Expressway, #250, Austin, TX
Signature
/s/ Erin R. McQuade, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jr. Michael Conick Hanley:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Aeglea BioTherapeutics, Inc. Chief Business Officer Employee Stock Option (right to buy) 500K Feb 23, 2023 Direct
Alto Neuroscience, Inc. Chief Operating Officer Employee Stock Option (right to buy) 188K May 20, 2024 Direct

Insider Reports Filed by Jr. Michael Conick Hanley

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ANRO Alto Neuroscience, Inc. May 20, 2024 1 $0 4 May 22, 2024 Chief Operating Officer
ANRO Alto Neuroscience, Inc. May 20, 2024 0 $0 3 May 22, 2024 Chief Operating Officer
AGLE Aeglea BioTherapeutics, Inc. Feb 23, 2023 1 $0 4 Feb 24, 2023 Chief Business Officer
AGLE Aeglea BioTherapeutics, Inc. Aug 23, 2022 1 $0 4 Aug 25, 2022 Chief Business Officer
AGLE Aeglea BioTherapeutics, Inc. Jun 8, 2022 1 $20K 4 Jun 10, 2022 Chief Commercial Officer
AGLE Aeglea BioTherapeutics, Inc. Feb 17, 2022 1 $0 4 Feb 22, 2022 Chief Commercial Officer